PPT-Selecting an Initial Antiretroviral Therapy (ART) Regimen

wwwhivguidelinesorg Purpose of This Guideline Provide a clear and concise roadmap for clinicians to follow in choosing from among several equally efficacious ART regimens based on individual patient characteristics and preferences. Jennifer Hoy. , MBBS. Professor of Medicine. Director, HIV Medicine. The Alfred Hospital. FINAL: 07-20-12. Phillip, Aged 67 Years. HIV infection diagnosed on screening for HBV treatment trial in 1995. Simi Padival, MD. November 3, 2016. Objectives. Learn about the importance of assessing adherence to antiretroviral therapy (ART). Learn about the components of assessing for ART adherence. Discuss frequency of monitoring while on ART. Module 10:. Pharmacovigilance. Background – definitions. Timeline of pharmacovigilance for a drug from development (pre-market) to post-marketing use. Burden of adverse drug reactions in children. Number of pharmacoepidemiological safety studies in children (Osokogu et al, 2016). This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States and data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.. Drew Lambert, . PharmD. lambertd@husson.edu. Husson University School of Pharmacy. 1. I have no conflicts of interest.. However, I will be using brand names extensively during the presentation. Majority of the drugs used are brand-only. Dr. S . Ntshalintshali. Ngwelezana. hospital. November 2016. HIV prevalence in RSA. The national estimate for HIV prevalence among South Africans in 2012 was 12.2. % (. 95% CI: 11.4–13.1). This estimate is statistically significantly different (p<0.001), from the 2008 national estimate of 10.6% (95% CI: 9.8–11.6). . ACTIVITY CODE . TD342. Antiretroviral Medications: . What . you need to know. Jason J. Schafer, PharmD, MPH, BCPS, AAHIVP. Associate Professor, Department of Pharmacy Practice. Joseph J. Eron, Jr, MD Professor of Medicine and Epidemiology The University of North Carolina at Chapel Hill Chapel Hill, North Carolina Future Directions: Investigational Approaches to Antiretroviral Therapy Treating and Preventing HIV in 2019: Interactive Cases From the Clinic(ians) Michael S. Saag , MD Professor of Medicine Associate Dean for Global Health Jim Straley Chair in AIDS Research University of Alabama at Birmingham Strength of the recommendationAPreferred should generally be offeredBAlternative acceptable to offerCOffer when preferred or alternative regimens cannot be givenDShould generally not be offeredEShould . Trikudanathan. , MD, MRCP, . MMSc. Division of Endocrinology, Metabolism and Nutrition. University of Washington Medical Center. Presentation prepared by: . S. . Trikudanathan. Presenter: S. . Trikudanathan. 1 Ju ne 2019 The New Standard Provider FAQ Early diagnosis of HIV infection, followed by prompt antiretroviral therapy ( ART ) initiation , expands the concept of universal ART . There are cle A5173 Study. Intensive . Enfuvirtide. -containing Antiretroviral Therapy . A5173: . Study Design. Source: Gandhi RT, et al. . J . Infect. . Dis. . . 2010;201(2. ):293-6.. Enfuvirtide. +. TDF + (FTC or 3TC) +. Supported by an educational grant from Gilead Sciences, Inc.. Gregory D. . Huhn. , MD, MPHTM. COVID-19 Vaccination Coordinator and Senior Director of HIV Services. Cook County Health. Associate Professor, Department of Internal Medicine, Division of Infectious Disease.